These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18261772)

  • 21. Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.
    Ijare OB; Hambarde S; Brasil da Costa FH; Lopez S; Sharpe MA; Helekar SA; Hangel G; Bogner W; Widhalm G; Bachoo RM; Baskin DS; Pichumani K
    Neuro Oncol; 2022 Apr; 24(4):556-568. PubMed ID: 34515312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse Models in Meningioma Research: A Systematic Review.
    Boetto J; Peyre M; Kalamarides M
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.
    Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q
    Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
    Zhang H; Qi L; Du Y; Huang LF; Braun FK; Kogiso M; Zhao Y; Li C; Lindsay H; Zhao S; Injac SG; Baxter PA; Su JM; Stephan C; Keller C; Heck KA; Harmanci A; Harmanci AO; Yang J; Klisch TJ; Li XN; Patel AJ
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSTR-2 as a potential tumour-specific marker for fluorescence-guided meningioma surgery.
    Dijkstra BM; Motekallemi A; den Dunnen WFA; Jeltema JR; van Dam GM; Kruyt FAE; Groen RJM
    Acta Neurochir (Wien); 2018 Aug; 160(8):1539-1546. PubMed ID: 29858948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in meningioma genetics: novel therapeutic opportunities.
    Preusser M; Brastianos PK; Mawrin C
    Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
    Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM
    Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.
    Khan I; Baeesa S; Bangash M; Schulten HJ; Alghamdi F; Qashqari H; Madkhali N; Carracedo A; Saka M; Jamal A; Al-Maghrabi J; AlQahtani M; Al-Karim S; Damanhouri G; Saini K; Chaudhary A; Abuzenadah A; Hussein D
    Cancer Cell Int; 2017; 17():72. PubMed ID: 28736504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.
    Wainwright DA; Horbinski CM; Hashizume R; James CD
    Neurotherapeutics; 2017 Apr; 14(2):385-392. PubMed ID: 28321824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
    Nigim F; Esaki S; Hood M; Lelic N; James MF; Ramesh V; Stemmer-Rachamimov A; Cahill DP; Brastianos PK; Rabkin SD; Martuza RL; Wakimoto H
    Neuro Oncol; 2016 Sep; 18(9):1278-87. PubMed ID: 26951380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
    Michelhaugh SK; Guastella AR; Varadarajan K; Klinger NV; Parajuli P; Ahmad A; Sethi S; Aboukameel A; Kiousis S; Zitron IM; Ebrahim SA; Polin LA; Sarkar FH; Bollig-Fischer A; Mittal S
    J Transl Med; 2015 Jul; 13():227. PubMed ID: 26174772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway.
    Das A; Miller R; Lee P; Holden CA; Lindhorst SM; Jaboin J; Vandergrift WA; Banik NL; Giglio P; Varma AK; Raizer JJ; Patel SJ
    Tumour Biol; 2015 Sep; 36(9):7027-34. PubMed ID: 25864108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.
    Soto-Montenegro ML; Peña-Zalbidea S; Mateos-Pérez JM; Oteo M; Romero E; Morcillo MÁ; Desco M
    PLoS One; 2014; 9(11):e111624. PubMed ID: 25369268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo.
    Senol O; Schaaij-Visser TB; Erkan EP; Dorfer C; Lewandrowski G; Pham TV; Piersma SR; Peerdeman SM; Ströbel T; Tannous B; Saydam N; Slavc I; Knosp E; Jimenez CR; Saydam O
    Oncogene; 2015 Apr; 34(14):1790-8. PubMed ID: 24858044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
    Iwami K; Natsume A; Ohno M; Ikeda H; Mineno J; Nukaya I; Okamoto S; Fujiwara H; Yasukawa M; Shiku H; Wakabayashi T
    Neuro Oncol; 2013 Jun; 15(6):747-58. PubMed ID: 23460320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
    Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma.
    Rath P; Miller DC; Litofsky NS; Anthony DC; Feng Q; Franklin C; Pei L; Free A; Liu J; Ren M; Kirk MD; Shi H
    Exp Mol Pathol; 2011 Apr; 90(2):179-88. PubMed ID: 21168406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningioma mouse models.
    Kalamarides M; Peyre M; Giovannini M
    J Neurooncol; 2010 Sep; 99(3):325-31. PubMed ID: 20734219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.
    Saydam O; Senol O; Schaaij-Visser TB; Pham TV; Piersma SR; Stemmer-Rachamimov AO; Wurdinger T; Peerdeman SM; Jimenez CR
    J Proteome Res; 2010 Jan; 9(1):485-94. PubMed ID: 19877719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.